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Abstract
A study has been carried out to determine the morphological changes to the
adult liver fluke, Fasciola hepatica after treatment in vivo with artemether. Rats
were infected with the triclabendazole-resistant Sligo isolate of F. hepatica, dosed
orally with artemether at a concentration of 200 mg/kg and flukes recovered at
24, 48 and 72 h post-treatment (p.t.). Surface changes were monitored by
scanning electron microscopy and fine structural changes to the tegument and
gut by transmission electron microscopy. Twenty-four hours p.t., the external
surface showed minor disruption, in the form of mild swelling of the tegument.
The tegumental syncytium and sub-tegumental tissues appeared relatively
normal. Forty-eight and seventy-two hours p.t., disruption to the tegumental
system increased, with isolated patches of surface blebbing and reduced
production of secretory bodies by the tegumental cells being the main changes
seen. The gastrodermal cells showed a relatively normal morphology 24 h p.t. By
48 h, large numbers of autophagic vacuoles and lipid droplets were present.
Autophagy increased in magnitude by 72 h p.t. and substantial disruption to the
granular endoplasmic reticulum was observed. Results from this study show
that flukes treated in vivo with artemether display progressive and time-
dependent alterations to the tegument and gut. Disruption to the gut was
consistently and substantially more severe than that to the tegument, suggesting
that an oral route of uptake for this compound predominates. This is the first
study providing ultrastructural information on the effect of an artemisinin
compound against liver fluke.
Introduction
Fasciola hepatica is a parasite of ruminant animals
prevalent in temperate regions across the world. It is a
species of considerable agricultural and economic
importance, with losses resulting from infection
estimated at US$2000–3000 million annually (Boray,
1994). In addition, fascioliasis has emerged as a major
zoonotic disease in many countries (Mas-Coma et al.,
2005), with an estimated 17 million people currently
infected and up to 180 million at risk (WHO, 2007).
During recent years, an upsurge in cases of fascioliasis in
livestock has been noted (Mitchell, 2002), which is
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Fig. 1. A–F, Scanning electron micrographs of the tegumental surface of adult triclabendazole-resistant Fasciola hepatica, 24 h p.t. in vivo
with 200 mg/kg artemether. (A) Ventral surface of the oral cone region, showing the oral sucker (OS), cirrus (C) and ventral sucker (VS).
Scale bar ¼ 500mm. Inset shows prominent spines (S) with apical spinelets (arrow). Scale bar ¼ 20mm. (B) Dorsal surface of the oral cone
152 J.F. O’Neill et al.
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0022149X09344934
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 15:24:16, subject to the Cambridge Core terms of use, available at
believed to be the result of climate-related changes in
distribution of the intermediate snail host, Galba
truncatula (Mitchell, 2002; Mas-Coma et al., 2005). Current
control of fascioliasis relies heavily on the drug of choice,
triclabendazole (TCBZ) (Fairweather, 2005, 2009; Keiser
et al., 2005), due to its almost unique efficacy against
both juvenile and mature flukes (Boray et al., 1983).
In the continued absence of an effective vaccine, chemo-
therapy will remain the mainstay of treatment for the
foreseeable future.
Fluke populations demonstrating resistance to TCBZ
have been well documented, with the first record on
Australian farms in the mid-1990s (Overend & Bowen,
1995). Since then, resistant populations have been reported
in Ireland, the Netherlands (references in Fairweather,
2005), Spain (A´lvarez-Sa´nchez et al., 2006) and much of the
UK, with mounting evidence suggesting that resistance is
underestimated and spreading (Wolstenholme et al., 2004).
The spread of resistance to the drug of choice creates
a significant need for new strategies for fluke control.
Such strategies should aim both at prolonging the life of
currently available drugs (Wolstenholme et al., 2004) as
well as addressing the need for effective novel compounds
to be introduced. One family of potential candidates
to be considered in the search for novel flukicides is
the artemisinins, derived from the wormwood plant,
Artemisia annua. The original parent compound,
qinghaosu, extracted in the 1960s in China as part of
a co-ordinated governmental effort to uncover novel
antimalarial compounds, was later named artemisinin
and, since this discovery, several semi- and fully-synthetic
derivatives have been developed (Woodrow et al., 2005;
Keiser & Utzinger, 2007). Today artemisinin derivatives
and artemisinin combination treatments are the first-line
drugs for uncomplicated falciparum malaria. In addition,
artemisinin derivatives are known to be effective against
juvenile stages of all major blood fluke species infecting
humans (Utzinger et al., 2007). Artemisinin-type com-
pounds have also been shown to be effective against
different food-borne trematodes such as Opisthorchis
viverrini (Keiser et al., 2006a) and Clonorchis sinensis in
rodents (Keiser et al., 2006a, 2007b). A number of
artemisinin compounds have been tested against
F. hepatica: the semi-synthetic artemether and artesunate
and the fully-synthetic trioxolane derivative, OZ78. They
show high efficacy against adult and juvenile flukes in the
rat model (Keiser et al., 2006b, c, 2007a). Recently,
preliminary studies have reported promising fasciolicidal
properties in sheep and even in humans (Hien et al.,
2008; Keiser et al., 2008). Significantly, both artemether and
OZ78 have shown substantial activity against the TCBZ-
resistant Oberon isolate in the rat host (Keiser et al., 2007a).
The aim of the current study was to evaluate
morphological changes to flukes belonging to another
TCBZ-resistant isolate of F. hepatica, the Sligo isolate,
following treatment in vivo in the rat model with
200 mg/kg artemether. Flukes were recovered at three
time-points post-treatment (p.t.) (24, 48 and 72 h), in an
attempt to determine a time-scale for drug action.
Morphological observations were made using scanning
and transmission electron microscopy and concentrated
on the tegument and gut. These tissues provide the
two main surfaces across which drugs can enter the
fluke and were selected in the hope of gathering
information on the route of uptake of artemether by the
fluke. This paper is the first to present ultrastructural
information on the effect of an artemisinin compound
against the liver fluke.
Materials and methods
Fluke material
The Sligo isolate of Fasciola hepatica used for the current
study was first reported in 1995 in county Sligo, Ireland
(Fairweather, 2005). It has been characterized as showing
resistance to the action of triclabendazole in vivo at
both adult and juvenile stages (Coles et al., 2000; Coles &
Stafford, 2001; McCoy et al., 2005; McConville et al.,
2009a), as well as resistance to the TCBZ metabolite,
triclabendazole sulphoxide in vitro (Robinson et al., 2002;
Mottier et al., 2006a). Six male Sprague–Dawley rats
under isoflurane anaesthesia were each orally infected, by
means of a stomach tube, with 20 metacercarial cysts of
the Sligo isolate of F. hepatica.
In vivo drug treatment
Five months post-infection, rats were weighed
individually and dosed orally with 200 mg/kg body
weight artemether. The stock solution used comprised
1.0 g of artemether dissolved in 7% (v/v) Tween 80 and
3% (v/v) ethanol. The dose used has been shown to effect
a 100% adult worm burden reduction in the TCBZ-
susceptible Cullompton isolate (Keiser et al., 2006b).
Following dosing, flukes were recovered from the bile
ducts at necropsy 24 h, 48 h and 72 h p.t. Eighteen flukes
were recovered in total, each of which was washed briefly
in NCTC 135 culture medium at 378C. Zero-hour
untreated specimens were prepared as controls. Speci-
mens were prepared for scanning electron microscopy
(SEM) and transmission electron microscopy (TEM) as
follows.
region (OC). Scale bar ¼ 100mm. Inset shows the regular and uniform arrangement of the spines (S). Scale bar ¼ 20mm. (C) Ventral
surface, midbody region showing the slight swelling of the interspinal tegument. Scale bar ¼ 100mm. Inset shows splitting of the
tegument (arrows) at the tips of the spines (S). Scale bar ¼ 20mm. (D) Dorsal surface of the midbody region. Scale bar ¼ 100mm. Inset
shows slight disruption (arrow) to the tegumental covering of the spines (S). Scale bar ¼ 20mm. (E) Ventral surface of the tail region,
showing swelling of the interspinal tegument. Scale bar ¼ 500mm. Inset shows a spine (S) which appears to be submerged by the swollen
tegument surrounding it. Scale bar ¼ 20mm. (F) Dorsal surface of the tail region, showing swelling of the interspinal tegument. Scale
bar ¼ 500mm. Inset shows the roughened surface of the tegument. The spines (S) are barely visible, due to the swelling of the tegument
surrounding them. Scale bar ¼ 20mm.
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Fig. 2. A–F, Scanning electron micrographs of the tegumental surface of adult triclabendazole-resistant Fasciola hepatica, 72 h p.t. in vivo
with 200 mg/kg artemether. (A) Ventral surface of the oral cone region, showing the oral sucker (OS), gonopore (GP) and ventral sucker
(VS). Scale bar ¼ 500mm. Inset shows well-defined spines (S) and smooth tegumental surface. Scale bar ¼ 20mm. (B) Dorsal surface
of the oral cone region. Scale bar ¼ 100mm. Inset shows slight disruption to spines (S), as the spinelets are poorly defined (arrow).
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Tissue preparation for SEM
Flukes were lightly flat-fixed for 1 h at room tempera-
ture in 4% (w/v) glutaraldehyde in 0.1M sodium
cacodylate buffer (pH 7.4). They were then free-fixed for
a further 3 h using fresh fixative before being post-fixed
in 1% osmium tetroxide for 1 h. Specimens were then
washed several times with cacodylate buffer before being
dehydrated in an ascending series of ethanol. Following
dehydration, flukes were dried using hexamethyldisila-
zane and mounted on aluminium stubs which were
sputter-coated with gold–palladium. Samples were
viewed using a FEI Quanta 200 scanning electron
microscope operating at an accelerating voltage of 10 keV.
Tissue preparation for TEM
Flukes were lightly flat-fixed for 1 h at room tempera-
ture in 4% (w/v) glutaraldehyde in 0.1M sodium
cacodylate buffer (pH 7.4). Specimens were then
dissected into oral cone, midbody and tail regions,
which were further split into transverse slices approxi-
mately 3 mm in thickness. These slices were free-fixed in
fresh fixative for 3 h, before being washed several times
in sodium cacodylate buffer. The samples were stored in
buffer overnight.
Following washing, fluke samples were post-fixed for
1 h in 1% osmium tetroxide, washed in buffer and
dehydrated through an ascending series of ethanol.
Fluke material was then embedded using Agar 100
resin. Ultrathin sections (,60–75 nm in thickness) were
cut on a Reichert Ultracut E ultramicrotome and
mounted on uncoated 200-mesh copper grids. The
sections were double-stained with alcoholic uranyl
acetate (9 min) and aqueous lead citrate (6 min) and
viewed in a FEI CM100 transmission electron micro-
scope at 100 keV.
Results
Visual observations
The flukes recovered from the untreated control rats
were very active and possessed full gut contents.
Twenty-four hours p.t. with artemether, recovered flukes
showed normal activity and gut contents were present.
No difference was observed between treated and control
specimens. Forty-eight hours p.t. with artemether, flukes
were highly active and gut contents were retained.
Seventy-two hours p.t. although still motile, the flukes
appeared sluggish in their movement. Gut contents were
again retained in all specimens.
Scanning electron microscopy
The surface architecture of the control flukes appeared
normal, matching the images presented by Bennett (1975)
and Fairweather et al. (1999).
Twenty-four hours post-treatment
Little disruption was evident to the surface of the flukes
in the oral cone region (fig. 1A and B). Tegumental spines
were prominent, regularly arranged and separated by a
smooth and uniform interspinal tegument (insets, fig. 1A
and B). Individual spinelets were clearly visible on the
spines (fig. 1A inset). The midbody region showed slight
swelling of the interspinal tegument on the ventral
surface (fig. 1C). At high magnification, disruption to the
spinelets was observed and, in some cases, there was
localized splitting of the tegument covering the spines
(fig. 1C inset). In contrast, there was minimal swelling on
the dorsal surface in this region, with a small number of
spines showing minor disruption of their tegumental
covering (fig. 1D and inset). In the tail region, the
interspinal tegument was swollen both ventrally
and dorsally, so that the spines appeared submerged
(fig. 1E and F). On the dorsal surface, the interspinal
tegument had a roughened and fibrous appearance
(insets, fig. 1E and F).
Forty-eight hours post-treatment
For economy of space, micrographs for the 48 h
treatment will not be included, but the results will be
described. On examination, the surface morphology of
the flukes was mostly normal, particularly in the oral cone
region. The midbody region of these flukes showed
isolated areas of tegumental swelling on the ventral
surface, with slight tegumental furrowing. On the dorsal
midbody surface there was mild swelling of the
interspinal tegument. In the tail region, flukes exhibited
substantial swelling of the interspinal tegument, causing
the spines to appear submerged by the tegument
surrounding them. This occurred to a similar extent on
both surfaces and was greater than that observed in the
24 h-treated specimens.
Seventy-two hours post-treatment
Specimens recovered 72 h after dosing displayed no
disruption to the ventral surface in the oral cone region
(fig. 2A and inset). In contrast, the dorsal surface
displayed a lack of spinelet definition due to minor
swelling of the tegument covering the spines (fig. 2B and
inset). In the midbody region, on both surfaces, swelling
of the interspinal tegument was observed. On the ventral
Scale bar ¼ 20mm. (C) Ventral surface of the midbody region, showing substantial disruption to the interspinal tegument which is
furrowed (F) and bears blebs (B). Scale bar ¼ 100mm. Inset shows the swelling of the interspinal tegument, as well as the loss of tegument
(arrows) on one of the spines (S). Scale bar ¼ 20mm. (D) Dorsal surface of the midbody region, demonstrating evidence of more
widespread blebbing (B) and swelling to the tegument. S, spines. Scale bar ¼ 100mm. Inset shows blebs (arrowed) forming at the tip of a
spine (S). Scale bar ¼ 20mm. (E) Ventral surface of the tail region. Scale bar ¼ 500mm. Inset shows normal spine morphology (S), and only
a slight swelling of the interspinal tegument is evident. Scale bar ¼ 20mm. (F) Dorsal surface of the tail region. Scale bar ¼ 500mm.
Inset shows swelling of the interspinal tegument with the spines (S) appearing to be submerged by the surrounding tegument.
Scale bar ¼ 20mm.
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Fig. 3. A–F, Transmission electron micrographs of the tegument and sub-tegumental tissues of adult triclabendazole-resistant Fasciola
hepatica, 24 h p.t. in vivo with 200 mg/kg artemether. (A) Tegument and sub-tegumental region, showing the full depth of the syncytium.
The basal infolds (BI) and basal lamina (BL) retain a normal morphology. The circular (CM) and longitudinal (LM) muscle bundles also
appear normal. Scale bar ¼ 3mm. (B) A high magnification micrograph of the apical region of the tegument. Type 1 (T1) and type 2 (T2)
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surface, this resulted in furrowing of the tegument and
some isolated spines showed a partial loss of their
tegumental covering (fig. 2C and inset). Swelling of the
interspinal tegument on the dorsal midbody surface
(fig. 2D) was coupled with disruption to the spine tips, as
evidenced by the loss of spinelets (fig. 2D inset). On both
dorsal and ventral surfaces there was a scattering of small
blebs (fig. 2C and D and inset), although this was more
evident on the dorsal surface (fig. 2D). The tail region of
72 h-treated specimens appeared reasonably unaffected,
with only the dorsal surface displaying significant
swelling of the interspinal tegument, so that the spines
appeared to be partially submerged (fig. 2E and F).
Transmission electron microscopy: tegument and sub-tegument
The ultrastructure of the tegumental system in the
control specimens remained normal, as described by
Threadgold (1963, 1967) and Fairweather et al. (1999).
Twenty-four hours post-treatment
The tegumental syncytium of flukes appeared normal,
with concentrations of tegumental secretory bodies at the
apex of the syncytium (fig. 3A and B). Slight swelling of
the mitochondria was visible and a few autophagic
vacuoles were present (fig. 3C). The basal infolds
appeared normal (fig. 3A and C) and the sub-tegumental
musculature (both circular and longitudinal) retained a
normal morphology (fig. 3D). Type 1 and type 2
tegumental cell bodies contained normal numbers of
their secretory bodies (fig. 3E). At higher magnification, a
number of Golgi complexes were observed (fig. 3F), many
of which possessed dilated and irregularly stacked
cisternae.
Forty-eight hours post-treatment
Again, no micrographs of this time period will be
included. The tegumental syncytium of flukes recovered
48 h p.t. with artemether appeared normal, with the basal
infolds and sub-syncytial basal lamina retaining a normal
morphology. The mitochondria appeared swollen in a
number of specimens, although no evidence of autophagy
was observed. Tegumental secretory bodies were present
in normal numbers and distribution within the syncy-
tium. The sub-tegumental musculature appeared normal
throughout, although the cytoplasmic connections from
the tegumental cells that run between the muscle blocks
appeared swollen and distended. In the tegumental cell
bodies, a large proportion of the Golgi complexes
contained dilated and irregularly stacked cisternae,
although there were normal numbers of secretory bodies
in the cells.
Seventy-two hours post-treatment
Flukes recovered from rats 72 h p.t. with artemether
displayed changes to the tegumental syncytium and
underlying tissues. In isolated areas of the syncytium, for
example, there was substantial swelling of the mucopo-
lysaccharide masses surrounding the basal infolds,
although the basal infolds themselves appeared normal
(fig. 4A). Both types of tegumental secretory body were
present in normal numbers and distribution throughout
the syncytium with a concentration at the apex (fig. 4B).
Gross swelling and distension of the cytoplasmic
connections was observed (fig. 4C and D), although the
muscle bundles appeared normal. Tegumental cell bodies
contained numerous Golgi complexes with irregularly
stacked and dilated cisternae, together with swollen
mitochondria (fig. 4F). The number of type 2 tegumental
secretory bodies present in the cells appeared normal
(fig. 4E), whereas there were few type 1 secretory bodies.
Transmission electron microscopy: gastrodermal cells
The gastrodermal cells of the control specimens
retained a normal morphology similar to that described
by Robinson & Threadgold (1975).
Twenty-four hours post-treatment
Twenty-four hours p.t. with artemether, the gastro-
dermal cells appeared relatively normal (fig. 5A). The
number of secretory vesicles in the cells was normal, but
they appeared somewhat elongated and irregularly
shaped. The cisternae of the granular endoplasmic
reticulum were swollen (fig. 5B(I) and B(II)).
Forty-eight hours post-treatment
Forty-eight hours p.t. large numbers of autophagic
vacuoles and lipid droplets were observed in the cells
(fig. 5C and D). The number of secretory vesicles present
appeared normal, although they were small and oddly
shaped. The cisternae of the granular endoplasmic
reticulum were dilated (fig. 5D).
Seventy-two hours post-treatment
Specimens viewed 72 h p.t. with artemether showed a
substantial increase in the level of autophagy and large
lipid droplets were present throughout the tissue (fig. 5E).
Dilation of the cisternae of the granular endoplasmic
reticulum was visible, even at low magnification (fig. 5E).
There were few secretory vesicles in the cells and they
appeared small and irregularly shaped (fig. 5F).
tegumental secretory bodies are present in normal numbers. Scale bar ¼ 1mm. (C) High-power image of the syncytium showing the
presence of autophagic vacuoles (AV), as well as slight distension of the mitochondria (m). The basal infolds (BI) appear normal. Scale
bar ¼ 1mm. (D) The circular (CM) and longitudinal (LM) muscle bundles appear normal. Scale bar ¼ 2mm. (E) Type 1 tegumental cell
body, containing a Golgi complex (G) and the nucleus (N). T1, type 1 secretory body. Scale bar ¼ 2mm. (F) High magnification view of the
Golgi complex (G) within a type 1 tegumental cell body. The complex appears abnormal, with swelling and distension of its cisternae. T1,
type 1 secretory body. Scale bar ¼ 1mm.
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Fig. 4. A–F, Transmission electron micrographs of the tegument and sub-tegumental tissues of adult triclabendazole-resistant Fasciola
hepatica, 72 h p.t. in vivo with 200 mg/kg artemether. (A) Tegument and sub-tegumental region, showing the basal infolds (BI) and basal
lamina (BL), which are normal. The mucopolysaccharide masses surrounding the basal infolds appear swollen and distended (arrow).
Scale bar ¼ 3mm. (B) High-power micrograph of the apical region of the tegument, showing the presence of normal numbers of type 1
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Discussion
In the present study, changes to the tegumental system,
the underlying musculature and gastrodermal cells were
examined over a 72-h period, to monitor the response of
the TCBZ-resistant fluke to treatment in vivo with
artemether. While disruption to the tegument was
relatively mild, the disruption to the gut became
increasingly severe with time, with accumulations of
lipid and extensive autophagic breakdown of the
gastrodermal cells. The results will be discussed in
terms of the time-course of drug action and the route of
uptake of artemether.
The changes to the tegumental surface were
relatively mild, not progressing beyond swelling and
areas of scattered blebbing. There was no spine loss or
tegumental sloughing, although there was some
disruption and splitting of the tegumental covering of
the spines. In previous SEM studies on F. hepatica
involving artemisinins, instances of more severe
blebbing, also spine loss and even sloughing have
been described (Keiser et al., 2006b, c; Keiser &
Morson, 2008a, b). Whether this is due to a different
response of this particular isolate of F. hepatica to
artemether is not known, although other studies on the
fluke have shown that different isolates respond in
different ways to the same drug (Walker et al., 2004;
McKinstry et al., 2007, 2009). That is, while the changes
seen are similar, the extent of those changes or degree
of disruption differs, so that the sensitivity of an isolate
to a particular drug varies. The present result may be
related to the TCBZ-resistant status of the Sligo isolate,
but this point needs to be examined further, with more
detailed analysis of the efficacy of artemisinin
compounds against different isolates of F. hepatica.
More dramatic changes to the fluke surface stem-
ming from in vivo treatment have also been observed
in studies with other flukicides: e.g. closantel (Skuce &
Fairweather, 1990), clorsulon (Meaney et al., 2003, 2006),
nitroxynil (McKinstry et al., 2003), TCBZ (Halferty et al.,
2008) and the TCBZ derivative, compound alpha
(McConville et al., 2008). The lack of serious disruption
to the surface morphology of the fluke was reflected
in the limited internal changes to the tegumental
system observed by transmission electron microscopy.
Transport of tegumental secretory bodies continued, as
evidenced by the numbers of secretory bodies in the
syncytium although, by 72 h p.t., production of type 1
secretory bodies had declined and there were few
secretory bodies in the cells. This decline in production
coincided with increasing disruption of the Golgi
complexes responsible for their packaging. In contrast,
production of type 2 secretory bodies remained normal
and numbers present in the cells remained high.
The tegumental secretory bodies are known to be
responsible for the maintenance of the apical tegumental
membrane (Fairweather et al., 1999), so ultimately their
decline would lead to severe disruption of the
syncytium: that point was not reached at 72 h p.t.
The results provide some idea of the time-scale of drug
action. For example, the reduction in motility that is
evident at 72 h p.t. This will compound the autophagic
disruption of the gut cells observed from 48 h p.t. onwards,
as the fluke is unable to feed when it becomes inactive
and essentially enters a state of starvation. The internal
changes triggered by the degeneration of the gut
are not manifested directly in any marked changes to
the tegumental system because, although progressive
changes to this tissue and to the external surface of the
fluke were observed, they were not very severe. So, drug
action is relatively slow, despite the relatively rapid
attainment of peak plasma levels and the short half-life of
artemether (Lefe`vre & Thomsen, 1999). Established
pharmacokinetic data for artemether, detailing a low
bioavailability when administered orally (19% in rats:
Li et al., 1998), suggests that artemether undergoes
extensive first-pass metabolism (Navaratnam et al., 2000).
The delayed drug effect observed in this study is consistent
with observations made in previous studies on F. hepatica
following treatment with artemether, artesunate and
OZ78. In those studies, the death and removal of flukes
was seen to take 72–96 h to become apparent (Keiser et al.,
2006b; Keiser & Morson, 2008a, b). The apparent
contradiction between drug peaks, drug half-life and
drug action has been seen in other drug studies on
F. hepatica (e.g. Meaney et al., 2003; McConville et al., 2008,
2009b). For these drugs, which are relatively slow-acting, it
may take some time before their action (and the
morphological changes they induce) to become apparent;
however, the effects are seemingly irreversible, as the drug
continues to act following its elimination from the host. In
contrast, the morphological changes induced by TCBZ
more closely match its pharmacokinetics in the host
(Halferty et al., 2008) and the data on nitroxynil fit this
pattern, too (McKinstry et al., 2003, 2007).
The gut was more severely affected than the tegument
at all time-points p.t. and the disruption became increas-
ingly severe with longer treatment times. There was a
progressive build-up of lipid droplets, disruption of the
granular endoplasmic reticulum cisternae and extensive
autophagy of the gastrodermal cells. The secretory
activity of the cells was progressively affected over time,
so that by 72 h p.t. few secretory vesicles were present.
This would compromise the ability of the fluke to
feed, compounding the effect of starvation referred to
previously. The presence of lipid droplets is an indication
of metabolic disruption in the cells, and the cells
themselves appeared to be undergoing breakdown, as
(T1) and type 2 (T2) tegumental secretory bodies. Scale bar ¼ 2mm. (C) The sub-syncytial cytoplasmic connections (cc) appear swollen
and distended. BL, basal lamina. Scale bar ¼ 2mm. (D) The circular muscle (CM) bundles appear normal, although the surrounding
cytoplasmic connections (cc) are swollen. Scale bar ¼ 1mm. (E) A type 2 tegumental cell body, containing type 2 secretory bodies (T2) and
a nucleus (N). Scale bar ¼ 2mm. (F) High magnification image of swollen mitochondria (m) and a disrupted Golgi complex (G) within a
type 1 tegumental cell body. The Golgi complex possesses dilated and irregular cisternae. T1, type 1 secretory body. Scale bar ¼ 1mm.
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Fig. 5. Transmission electron micrographs of gastrodermal cells from adult triclabendazole-resistant Fasciola hepatica 24 h (A and B), 48 h
(C and D) and 72 h (E and F) p.t. in vivo with 200 mg/kg artemether. (A) Gastrodermis showing an epithelial cell containing a nucleus (N).
Lamellae (La) project from the cell surface into the lumen. Scale bar ¼ 3mm. (B(I)) High magnification image of secretory vesicles (SV) in
the apical region of a gastrodermal cell. Lamellae (La) project from the surface of the cell. Scale bar ¼ 1mm. (B(II)) High magnification
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evidenced by the presence of autophagic vacuoles.
Comparing the results for the tegument and gut, it
seems most likely that oral uptake is the predominant
route of entry for artemether, rather than trans-tegu-
mental diffusion. This ties in with what is known about
drug entry and activation in schistosomes. For these
parasites, it has been suggested that the artemisinins need
to be ingested by the flukes in order for drug activation to
occur (Xiao et al., 2003). Drug activation depends on the
presence of an iron-containing compound, as would be
derived from haemoglobin in the blood, and this leads to
cleavage of the peroxide bridge in the drug molecule and
the generation of free radicals. It is these free radicals
which are damaging to the parasite (Xiao et al., 2003).
A similar mechanism may operate in F. hepatica, because
of its haematophagous feeding behaviour. In support of
this idea, greater disruption to the tegument of the liver
fluke was observed in vitro when haemin was incorpor-
ated into the culture medium (Keiser & Morson, 2008a, b).
Entry of an artemisinin compound across the tegument
would not allow the interaction between the drug and an
iron compound, and this would lead to a reduction in its
activity. Oral uptake of drug is also the predominant
mechanism for the fasciolicides, clorsulon and nitroxynil
(Meaney et al., 2005a, b, c; McKinstry et al., 2007). It is not a
universal phenomenon among fasciolicides, however,
because entry of TCBZ has been shown to take place
principally across the tegument (Mottier et al., 2006b;
Toner et al., 2009). So, for artemether, its activation and
efficacy are dependent on oral intake from the blood by
the fluke, rather than relying on trans-tegumental
diffusion as the drug is being excreted in the bile.
Some correlation can be made between the changes
seen and the known action of artemisinins, via the
production of free radicals. For example, treatment with
artemisinins and free radicals causes collapse of the
membrane potential of mitochondria, leading to their
swelling and inhibition of electron transfer and oxidative
phosphorylation (Dubin & Stoppani, 2000; Wakabayashi
& Karbowski, 2001; Li et al., 2005). This action could
explain the mitochondrial changes seen and would have
a significant impact on energy production by the fluke,
contributing to the state of general ill-health. Such
changes are also known to be part of the process leading
to cell death, or apoptosis (Dubin & Stoppani, 2000;
Wakabayashi & Karbowski, 2001; Li et al., 2005).
Furthermore, artemisinins and free radicals are known
to cause the oxidation of membrane proteins, such as ion
pumps (Rohn et al., 1996; Berman & Adams, 1997; Mason
et al., 1997; Sumegi et al., 2005). One target of artemisinin
action in malarial parasites is the sarco(endo)plasmic
reticulum Ca2þ-ATPase, which regulates calcium levels
within the parasite (Eckstein-Ludwig et al., 2003; Jung
et al., 2005; Uhlemann et al., 2007). The swelling of the
granular endoplasmic reticulum cisternae seen in the
present study could be due to inhibition of pumps
associated with their membranes. It would severely
affect the synthetic activity of the cells.
This study has shown that artemether treatment of a
TCBZ-resistant isolate of F. hepatica induces progressive
changes to the morphology of the fluke and that the
changes are more severe in the gastrodermal cells than the
tegument. This observation suggests that the drug enters
the fluke via the oral route, but this idea could be tested
further in experiments involving ligatures (to block the
oral route) and the incorporation of haemin in the
incubation medium (to activate the drug); similar
experiments have been carried out previously on fluke
(Meaney et al., 2005a, b, c; Mottier et al., 2006b; Keiser &
Morson, 2008a, b; Toner et al., 2009). In addition to the
severe disruption of the gut, artemether causes consider-
able disruption to the reproductive tissues (vitelline cells
and testes) and this will be published in a separate
communication.
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